In vivo follow-up of gene inhibition in solid tumors using peptide-based nanoparticles for sirna delivery

HIGHLIGHTS

• who: Isabel Ferreiro and collaborators from the VIVOPTIC TBM-Core, Université de Bordeaux, CNRS UMS, INSERM US, Bordeaux, France have published the Article: In Vivo Follow-Up of Gene Inhibition in Solid Tumors Using Peptide-Based Nanoparticles for siRNA Delivery, in the Journal: Pharmaceutics 2021, 13, 749. of /2021/
• what: This study was designed to show the in vivo efficiency of a new peptide (WRAP5) able to form peptidebased nanoparticles (PBN) that can deliver siRNA to cancer cells in solid tumors.
• future: Experiments are needed to gain a comprehensive picture of the situation . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.